ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 160 filers reported holding ANTARES PHARMA INC in Q2 2020. The put-call ratio across all filers is 2.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,411,000 | +57.3% | 344,200 | +37.0% | 0.28% | +72.6% |
| Q4 2021 | $897,000 | +9.1% | 251,200 | +11.2% | 0.16% | -3.5% |
| Q3 2021 | $822,000 | -6.1% | 225,900 | +12.6% | 0.17% | -11.5% |
| Q2 2021 | $875,000 | +6.2% | 200,600 | 0.0% | 0.19% | +13.6% |
| Q1 2021 | $824,000 | +3.0% | 200,600 | 0.0% | 0.17% | -19.9% |
| Q4 2020 | $800,000 | +47.6% | 200,600 | 0.0% | 0.21% | +15.9% |
| Q3 2020 | $542,000 | -1.8% | 200,600 | 0.0% | 0.18% | -16.1% |
| Q2 2020 | $552,000 | +16.7% | 200,600 | 0.0% | 0.22% | -16.9% |
| Q1 2020 | $473,000 | -10.4% | 200,600 | +78.6% | 0.26% | +48.3% |
| Q4 2019 | $528,000 | – | 112,300 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 500,000 | $2,055,000 | 4.58% |
| Centric Wealth Management | 3,337,449 | $13,717,000 | 3.92% |
| Sargent Investment Group, LLC | 3,599,580 | $14,794,000 | 3.90% |
| Rubric Capital Management LP | 8,722,647 | $35,850,000 | 2.09% |
| PERKINS CAPITAL MANAGEMENT INC | 542,283 | $2,229,000 | 1.29% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,900,000 | $7,809,000 | 1.17% |
| Venator Capital Management Ltd. | 550,000 | $2,624,000 | 0.89% |
| LEVEL FOUR FINANCIAL, LLC | 120,000 | $493,000 | 0.23% |
| ALGERT GLOBAL LLC | 147,616 | $607,000 | 0.19% |
| Brown Advisory Securities, LLC | 275,000 | $1,130,000 | 0.19% |